Banishing Blind Spots

Langreth, Robert
November 2006
Forbes Asia;11/13/2006, Vol. 2 Issue 19, p102
The article reports on the efforts by several companies to develop macular degeneration treatments. Genetic breakthroughs and an unlikely drug offer hope for a disease ravaging the eyes of an aging population. Two breakthrough drugs from Genentech offer hope for patients with the more severe wet form of age-related macular degeneration. At least 18 companies are now pursuing macular degeneration treatments, including stem-cell treatments.


Related Articles

  • Genentech Makes Lucentis More Widely Available.  // Review of Ophthalmology;Apr2008, Vol. 15 Issue 4, p7 

    The article reports that Genentech Inc. has implemented enhancements to the patient and provider support programs for Lucentis in the U.S. The enhancements aimed to improve enrollment timing and widen eligibility requirements. The company was able to discuss enhancements with the American...

  • DRUG TREATMENT SAID TO IMPROVE VISION OF THOSE WITH MACULAR DEGENERATION.  // Journal of Visual Impairment & Blindness;Nov2005, Vol. 99 Issue 11, p725 

    The article reports that clinical trials has demonstrated Lucentis as an effective treatment for wet age-related macular degeneration. This in addition to the drug Macugen that has been available since January 2005. Lucentis manufacturer Genentech reported that monthly injections of the drug...

  • Treatment of age-related macular degeneration. Browning, Andrew C.; Amoaku, Winfried M.; Dua, Harminda S. // Journal of the Royal Society of Medicine;Apr2004, Vol. 97 Issue 4, p166 

    The article examines the treatment employed in curing age-related macular degeneration (ARMD). It is an eye disease which happens to be the leading cause of blindness among older populations of the industrialized world. ARMD is classified into dry and wet forms of disease. For many years, laser...

  • Oxygen therapy and ophthalmology. Gorman, Des // Oman Journal of Ophthalmology;Oct2013 Special Issue, Vol. 6 Issue 4, pS5 

    The article offers information on the use of oxygen therapy in ophthalmology. This therapy can have a positive effect on patients having epidemic disorders such as macular degeneration and glaucoma. Many elderly patients are undergoing oxygen therapy for non-healing wounds and changes in visual...

  • Many treatments for wet macular degeneration. Donohue, Paul G. // Adirondack Daily Enterprise;6/1/2010, Vol. 117 Issue 129, p6 

    The article provides an answer to a question on treatments for wet macular degeneration.

  • DRUGS TO TREAT AGE-RELATED MACULAR DEGENERATION COMPARED IN TRIAL.  // Journal of Visual Impairment & Blindness;Mar2008, Vol. 102 Issue 3, p178 

    The article focuses on the trial initiated by the U.S. National Institutes of Health (NIH) in February 2008, on two Genentech drugs designed to treat the wet form of age-related macular degeneration (AMD), which occurs when abnormal blood vessel growth harms or destroys part of the eye. The...

  • Sources of retinal pigment epithelium (RPE) for replacement therapy. E Lee // British Journal of Ophthalmology;Apr2011, Vol. 95 Issue 4, p445 

    Stem cells, with their capacity to regenerate and replace diseased tissues, have recently been proposed as having great potential in the treatment of age-related macular degeneration (AMD). A stem cell therapeutic approach could operate to replace either the retinal pigment epithelium (RPE), the...

  • AMD stem cell 'first'. O'Hare, Ryan // Optometry Today;9/19/2014, Vol. 54 Issue 18, p5 

    The article describes the world's first stem cell treatment for age-related macular degeneration (AMD) performed on a 70-year-old woman at the Biomedical Research and Innovation in Kobe, Japan by researchers of the RIKEN Centre for Developmental Biology (CDB) on September 12, 2014.

  • Value of a soft cell. Brooks, Michael // New Statesman;12/6/2010, Vol. 139 Issue 5030, p11 

    The article examines the therapeutic uses of stem cells in medicine. It is noted that an experiment is underway using stem cells to restore the sight of several persons who possess degenerative retinal cells. A number of topics are addressed including the illegality of stem cell research in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics